ThomsonMed: Thomson Fertility Centre has been suspended from new assisted reproduction(AR) facilities. Due to news that the centre had a mix up during IVF treatment. A baby obtained through IVF had different DNA from the supposed father...
Existing patients who have commenced AR will be informed and be given a choice of whether to continue or transfer to other centres. As of FY2010, the relevant segment, Spec and Other Services, contributed approx 29.4% of rev and 18.2% of operating profit…
The likely response for remaining shareholders would be to accept the mandatory offer. With the delisting of Thomson, Raffles Medical will be a beneficiary for fund flows for investors. Furthermore, Raffles Medical will benefit from patients seeking to transfer for IVF treatments.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment